Judge Approved CVS Unit Omnicare Bankruptcy Plan
The pharmacy services division sold its operations for $250 million, settling a nearly $1 billion billing judgment.
Updated on Sept. 21, 2026 in Healthcare
Live Poll
Should large pharmacy companies face stricter financial penalties when they commit billing fraud?
A federal judge in the Northern District of Texas approved the Chapter 11 bankruptcy plan for CVS unit Omnicare. The plan includes the $250 million sale of the pharmacy services division and full payment to creditors.
Why it matters
Omnicare sought bankruptcy protection after accumulating billions in debt and facing a $949 million judgment for improper government billing. The resolution requires CVS to satisfy significant outstanding penalties to the Department of Justice through structured payments.
Omnicare settled a $949 million judgment for improper billing vs. a $250 million sale price for its business operations. CVS has committed to paying the Department of Justice $130 million within two weeks and $310 million by March 2028.
The players
CVS
A major American healthcare retail and pharmacy services company with a sprawling national footprint.
Omnicare
A pharmacy services provider formerly operated as a division of CVS.
Department of Justice
The federal executive department responsible for enforcing laws and prosecuting improper billing cases.
Stacey G. C. Jernigan
A judge in the Northern District of Texas who presided over the bankruptcy proceedings.
GenieRx Holdings
A partnership between Milrose Capital and Integro Asset Management that purchased Omnicare assets.
The details
The approved plan reorganizes remaining assets while liquidating others, facilitating the sale of the pharmacy unit to GenieRx Holdings. GenieRx Holdings is a partnership formed by Milrose Capital and Integro Asset Management. CVS remains responsible for fulfilling the settlement obligations to the Department of Justice as part of the bankruptcy resolution.
Timeline
2015: CVS acquired Omnicare.
July 2025: Federal judge ordered a $949 million penalty payment.
September 2025: Omnicare filed for Chapter 11 bankruptcy.
May 2026: Judge Jernigan approved the sale of Omnicare assets.
October 2026: Bankruptcy plan goes into effect.
Market Landscape
The resolution of Omnicare follows the pattern established by historic False Claims Act settlements against pharmacy operators. This outcome highlights how major healthcare conglomerates isolate legal liabilities through bankruptcy to divest underperforming or high-risk segments.
Operators should monitor how parent companies manage legal liabilities when selling off specialized pharmacy divisions. Ensure that your own billing and compliance documentation can withstand regulatory audits to avoid the high costs of long-term litigation.
The takeaway
This case underscores the financial risks inherent in large-scale government healthcare billing. Business owners should periodically audit internal compliance systems to prevent the accumulation of liabilities that necessitate future divestments or bankruptcy filings.
What happens next
CVS is scheduled to pay $130 million to the Department of Justice within two weeks of the settlement agreement and $310 million by the end of March 2028.
Further reading
For more on the regulatory and financial pressures affecting large pharmacy chains, visit Healthcare.
Source note: This article includes information reported by Healthcare Dive.
Live Poll
Should large pharmacy companies face stricter financial penalties when they commit billing fraud?
